ZNF277

ZNF277 is an evolutionarily conserved C2H2 zinc finger protein that operates at the interface of transcriptional regulation, ribosome biology, and RNA metabolism, with a recurring role in promoting cell proliferation (PMID:35015732, PMID:31114246). As a transcriptional regulator it directly represses growth-suppressive genes: it binds the PTEN promoter to repress PTEN and drive proliferation, migration, and invasion in cancer cells (PMID:31114246), and it represses p21WAF1 so that its loss induces p21WAF1 and triggers senescence (PMID:35015732). ZNF277 is itself a transcriptional target of β-catenin signaling, with two β-catenin binding sites in its promoter, and its deficiency attenuates intestinal epithelial proliferation and tumor formation in ApcMin/+ mice, placing it downstream of Wnt/β-catenin in intestinal tumorigenesis (PMID:35015732). Independently of its promoter-binding role, ZNF277 uses its C2H2 zinc finger domain to bind the 40S ribosomal protein uS5 (RPS2), forming an extraribosomal complex in the cytoplasm and nucleolus; it recognizes nascent uS5 cotranslationally and competes with PRMT3 for uS5 binding (PMID:30530495). This ribosome-associated function is conserved, as the C. elegans ortholog ZTF-7 interacts with the uS5 ortholog RPS-2 and is required for stimulus-induced depletion of the RNA exosome from nucleoli (PMID:36763670). ZNF277 also behaves as a multi-functional RNA-binding protein, binding thousands of RNA targets preferentially near transcription start sites and contributing to splicing, polyadenylation, stability, and/or translation (PMID:39303722).

1. 2000 Low

   Established ZNF277 as a discrete gene, defining it as a novel C2H2 zinc finger protein and providing the molecular starting point for all later functional work.

   Evidence Genomic mapping and sequence analysis localizing the gene to 7q31.1

   PMID:10860669

   Open questions at the time

   • Computational/genomic characterization only, no functional experiments
   • No protein function, partners, or localization defined
2. 2014 Medium

   Resolved whether ZNF277 is regulated independently of its neighboring genes within a recurrent microdeletion region, showing it is a separately controlled locus.

   Evidence Quantitative RT-PCR in individuals carrying natural microdeletions

   PMID:24518835

   Open questions at the time

   • Does not assign a molecular function to ZNF277
   • Phenotypic consequences of reduced ZNF277 not mechanistically defined
3. 2017 Low

   First functional knockdown linking ZNF277 to maintenance of a differentiated cell program, indicating it supports expression of cytoskeletal genes.

   Evidence siRNA knockdown in primary mouse podocytes with expression readout

   PMID:28709640

   Open questions at the time

   • Single knockdown within a large multi-gene screen, no defined pathway
   • Direct vs indirect regulation of CD2AP/synaptopodin not established
4. 2018 High

   Defined a non-transcriptional, ribosome-associated function by showing ZNF277 binds the 40S protein uS5 cotranslationally and competes with PRMT3, establishing it as a regulator of uS5 protein interactions.

   Evidence Quantitative proteomics, reciprocal Co-IP, C2H2 domain mutagenesis, overexpression/depletion, and fractionation in human cells

   PMID:30530495

   Open questions at the time

   • Functional consequence of ZNF277-uS5 binding for ribosome assembly or translation not resolved
   • Significance of PRMT3 competition for uS5 methylation untested
5. 2019 Medium

   Identified ZNF277 as a direct transcriptional repressor of PTEN, providing a mechanism for its tumor-promoting activity.

   Evidence ChIP and luciferase reporter assays with loss-/gain-of-function and PTEN rescue in ovarian cancer cell lines

   PMID:31114246

   Open questions at the time

   • Single lab, single tumor context
   • Co-repressor partners and DNA-binding motif not defined
6. 2022 High

   Placed ZNF277 in the Wnt/β-catenin axis and established its in vivo role in tumorigenesis, showing it is induced by β-catenin and represses p21WAF1 to suppress senescence.

   Evidence ChIP for β-catenin promoter binding, RNA-Seq, siRNA knockdown, and ApcMin/+ mouse loss-of-function

   PMID:35015732

   Open questions at the time

   • Direct vs indirect repression of p21WAF1 promoter not fully resolved
   • Mechanism linking β-catenin-driven ZNF277 to its ribosomal/RNA functions unknown
7. 2023 Medium

   Showed the ZNF277-uS5 interaction is evolutionarily conserved and tied to nucleolar RNA exosome dynamics, expanding its ribosomal role beyond human cells.

   Evidence Forward genetic screen, IP-MS, and RNAi depletion of the C. elegans ortholog ZTF-7 and RPS-2

   PMID:36763670

   Open questions at the time

   • Mechanism by which ZTF-7/RPS-2 controls exosome nucleolar depletion unclear
   • Conservation of exosome regulation in human ZNF277 not tested
8. 2024 Medium

   Broadened ZNF277's molecular identity from a DNA-binding repressor to a multi-functional RNA-binding protein, showing it binds thousands of RNAs near transcription start sites.

   Evidence Systematic multi-omics RNA interactome mapping across >100 zinc finger proteins

   PMID:39303722

   Open questions at the time

   • Specific RNA targets and regulatory outcomes for ZNF277 not individually validated
   • Relationship between DNA-proximal and RNA-proximal binding not mechanistically integrated

• How ZNF277's distinct activities — promoter repression of PTEN/p21WAF1, cotranslational uS5 binding, and broad RNA association — are coordinated within a single protein remains unresolved.
• No structural model of DNA, RNA, or uS5 recognition by the C2H2 domain
• No unified model connecting transcriptional and ribosomal/RNA functions
• DNA-binding consensus motif not defined